Starling Oncology, Inc. Convertible Preferred Stock, Shares Issued upon Conversion
Starling Oncology, Inc. (STLN) had Convertible Preferred Stock, Shares Issued upon Conversion of 100 shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Equity
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2026-08-06
- 2026-06-30: Convertible Preferred Stock, Shares Issued upon Conversion 100.00 shares.
- 2026-03-31: Convertible Preferred Stock, Shares Issued upon Conversion 100.00 shares.
- 2025-12-31: Convertible Preferred Stock, Shares Issued upon Conversion 100.00 shares.
- 2025-09-30: Convertible Preferred Stock, Shares Issued upon Conversion 100.00 shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion |
|---|---|
| 2026-06-30 | 100.00 shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 100.00 shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 100.00 shares 10-K · filed 2026-03-12 |
| 2025-09-30 | 100.00 shares 10-Q · filed 2025-11-13 |
| 2025-06-30 | 100.00 shares 10-Q · filed 2025-08-13 |
| 2025-03-31 | 100.00 shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 100.00 shares 10-K · filed 2025-03-26 |
| 2024-09-30 | 100.00 shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 100.00 shares 10-Q · filed 2024-08-13 |
| 2024-03-31 | 100.00 shares 10-Q · filed 2024-05-14 |
| 2023-12-31 | 100.00 shares 10-K · filed 2024-03-28 |
| 2023-09-30 | 100.00 shares 10-Q · filed 2023-11-08 |
| 2023-06-30 | 100.00 shares 10-Q · filed 2023-08-09 |
| 2023-03-31 | 100.00 shares 10-Q · filed 2023-05-10 |
| 2022-12-31 | 100.00 shares 10-K · filed 2023-03-16 |
| 2022-09-30 | 100.00 shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 100.00 shares 10-Q · filed 2022-08-09 |
| 2022-03-31 | 100.00 shares 10-Q · filed 2022-05-10 |
| 2021-12-31 | 100.00 shares 10-K · filed 2022-03-11 |